Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

72.42
Delayed Data
As of Dec 02
 -0.42 / -0.58%
Today’s Change
71.39
Today|||52-Week Range
105.57
-28.43%
Year-to-Date
3 Reasons Why Incyte Corporation Stock Could Soar in 2017
6:52am / MotleyFool.com - Paid Partner Content
3 Inexpensive Top Stocks You've Overlooked This Fall
Nov 23 / MotleyFool.com - Paid Partner Content
Forget Pfizer: Here Are 3 Better Dividend Stocks
Dec 02 / MotleyFool.com - Paid Partner Content
When Will Gilead Sciences' Unlucky Streak End?
Nov 23 / MotleyFool.com - Paid Partner Content
'Yuge' Sector Rotation Will Continue
Dec 01 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Acorda Stops Ampyra PSWD Development, CRL for Spectrum's Qapzo...
Nov 23 / Zacks.com - Paid Partner Content
Gilead Sciences, Inc.'s $10 Billion Mistake
Dec 01 / MotleyFool.com - Paid Partner Content
What Happened in Biotech in 2016?
Nov 22 / MotleyFool.com - Paid Partner Content
'Mad Money' Lightning Round: Gilead Sciences, Celgene, Express Scripts
Dec 01 / TheStreet.com - Paid Partner Content
Are Biogen and Gilead Sciences in Denial?
Nov 22 / MotleyFool.com - Paid Partner Content
5 Things Gilead Sciences' CEO Just Said That You Need to Know
Nov 30 / MotleyFool.com - Paid Partner Content
Attention, Biotech Investors: Black Friday Is Already Here
Nov 21 / MotleyFool.com - Paid Partner Content
17 Questions With Gaspare Civiero of the Value Investor
Nov 30 / GuruFocus News - Paid Partner Content
5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them
Nov 20 / MotleyFool.com - Paid Partner Content
Gilead Is a Strong Contrarian 'Buy'
Nov 29 / GuruFocus News - Paid Partner Content
The No. 1 Healthcare Concern Americans Want Donald Trump to Fix -- and It's Not Obama...
Nov 20 / MotleyFool.com - Paid Partner Content
Visualizing Financial Trends With Interactive Charts, Other Topics
Nov 29 / GuruFocus News - Paid Partner Content
Court rules NHS can provide anti-HIV drug
Nov 10 / FT.com - Paid Partner Content
Some 'January Effect' Stock Picks
Nov 28 / TheStreet.com - Paid Partner Content
Clinton defeat provides antidote to US drugmakers
Nov 10 / FT.com - Paid Partner Content
J&J (JNJ) Reportedly Approaches Actelion for Acquisition
Nov 25 / Zacks.com - Paid Partner Content
Drug and biotech stocks soar on Trump victory
Nov 09 / CNNMoney.com
The Worst Growth Dividend Stocks of 2016
Nov 23 / MotleyFool.com - Paid Partner Content
US stocks defy fears of panic with steady open after Trump win
Nov 09 / FT.com - Paid Partner Content
Galapagos (GLPG) Filgotinib in Phase III for Crohn's Disease
Nov 23 / Zacks.com - Paid Partner Content